Rock Tech Lithium’s AGM Sanctions Share Consolidation as €750 Million Funding Gap Chills Guben Ambitions

Rock Tech Lithium's AGM authorized a reverse split, but low turnout and a €750 million funding shortfall for the Guben lithium converter project remain critical hurdles.

Rock Tech Lithium’s annual meeting on June 26 handed management the authorisation to consolidate shares, but the low attendance – just 5.6% of outstanding stock was represented – betrayed the market’s lack of conviction. While all agenda items were waved through, the real test lies in whether the company can plug a €750 million financing hole before its flagship lithium hydroxide converter in Guben can break ground.

Directors Dirk Harbecke and Michelle Gahagan were re-elected with near-unanimous support, and the resolution enabling a reverse share split cleared the floor without resistance. The move, however, remains conditional on approval from the TSX Venture Exchange, and the board has yet to indicate timing. Share consolidation can improve a stock’s optics for institutional investors and exchange listings, but it does nothing to address the immediate capital shortfall.

That shortfall is the central bottleneck. The Guben project, which is designed to produce 24,000 tonnes of battery-grade lithium hydroxide annually and has been classified as strategically important by the European Union, cannot move forward without private investment. Company officials acknowledged at a recent municipal council meeting that no binding commitments from private partners have been secured, and without them, public subsidies remain frozen. The management team is understood to be in parallel talks with potential lenders, but no timeline for a final investment decision has been set. Once a green light is given, construction is expected to take two and a half years.

Alongside the Guben effort, Rock Tech is advancing a second project in Ontario, Canada. The Red-Rock development essentially replicates the Guben blueprint, but is integrated directly with the company’s own Georgia Lake spodumene resource, creating a closed-loop supply chain for North American offtakers. This dual-continent strategy gives the company two parallel growth paths, yet both depend on securing meaningful financing.

The stock market has priced in the uncertainty. Shares closed at €0.50, a level that marks a decline of roughly 10% to 13% over the past month depending on the measurement period. The stock has slipped below its 50-day moving average by 11% and the relative strength index sits at 38, indicating persistent selling pressure. From its 2026 high of €0.79, the equity has lost about 36%. On the positive side, the share price still holds a year-to-date gain of some 6%, and the 52-week low of €0.41 provides a technical floor that could support a base-building process.

For now, the company’s immediate priority is clear: secure binding commitments from private capital providers. Only when that private money is in place can public funding be unlocked, and only then can a final investment decision on Guben move within reach. The AGM may have given management the tools to restructure the equity, but the real heavy lifting remains ahead.